Search
Research
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.
Smoking + BMI in heart disease
WGS for cardiovascular outcomes
RNA-Seq in pancreatic cancer
Immune Checkpoint Blockade for Relapsed Hematologic Malignancy Post-HSCT
Request Access
Overview
Selected Publications (4)
Variables (5)
Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
M. Davids, Haesook T. Kim, P. Bachireddy, et al. (2016). The New England journal of medicine. Cited 334 times.
https://doi.org/10.1056/NEJMoa1601202
A multicenter, phase I study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
M. Davids, Haesook T. Kim, C. Costello, et al. (2020). Blood. Cited 63 times.
https://doi.org/10.1182/blood.2019004710
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
L. Penter, Yi Zhang, A. Savell, et al. (2021). Blood. Cited 32 times.
https://doi.org/10.1182/blood.2021010867
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
L. Penter, S. Gohil, Teddy Huang, et al. (2021). Blood Advances. Cited 11 times.
https://doi.org/10.1182/bloodadvances.2021004335
